[Dibekacin in bronchopulmonary infectious pathology].

Abstract

Thirty six patients in an intensive care unit with a bacterial bronchopulmonary infection were treated with intraparenteral dibekacin at a dose of 3 mg/kg/day. Mean age of the patients was 55 years and the mean duration of treatment 14 days. Biological material was obtained by fibro-aspiration or pleural tap. One or more organisms were identified in 36 cases. These were essentially staphylococci and Gram negative bacilli sensitive to dibekacin. Results showed a favourable course in 26 cases and a clinical improvement in 10. Clinical and biological tolerance was good. No clinical manifestations of cochleo-vestibular toxicity were seen.

• Authors: F Gouin, F Basse, D Robert, C Auboyer
• Journal: La Nouvelle presse medicale (Nouv Presse Med) Vol. 11 Issue 46 Pg. 3447-50 (Nov 18 1982) ISSN: 0301-1518 [Print] France
• Vernacular Title: La dibékacine en pathologie infectieuse bronchopulmonaire.
• PMID: 7155856 (Publication Type: English Abstract, Journal Article)

Chemical References

• Dibekacin
• Kanamycin

Topics

• Adult
• Aged
• Bacterial Infections (drug therapy)
• Dibekacin (therapeutic use)
• Female
• Humans
• Intensive Care Units
• Kanamycin (analogs & derivatives)
• Lung Diseases (drug therapy)
• Male
• Middle Aged